Earnings Report: Express Scripts Tears Estimates Up, Posts Inline Guidance (ESRX)

Express Scripts (NASDAQ:ESRX) reported Q2 EPS of $0.60, ex-items, topping consensus of $0.59.

Revenue in the quarter came in at $11.29 billion, vs. consensus estimates of $11.35 billion.

Express Scripts sees FY2010 adjusted EPS of $2.45-$2.50, vs. consensus estimates of $2.49.

Express Scripts, Inc is a full service pharmacy benefit management and specialty managed care company serving clients throughout North America. The Company's customers include managed care organizations, insurance carriers, third party administrators, employers, and union-sponsored benefit plans. Express provides pharmacy network management, formulary management, and other services.

SmarTrend alerted subscribers to take profits in Express Scripts on May 06, 2010 at $44.94, since then the stock fell 6.1%. We are now watching for any positive developments that could result in a new uptrend signal.

Category:

News & Politics

Tags:

• ESRX
• Q2
• smartrend
• trade
• the
• trend
• stock
• market
• news